Cannabiskonsum in der Schweiz: Prävalenz und Determinanten für Risikokonsum

Suchttherapie

Volumn 6, Issue 3, 2005, Pages 126-132

  Neuenschwander, M ^a   Frick, U ^a,b   Gmel, G ^c   Rehm, J ^a,d  

^a Institut fur Sucht und Gesundheitsforschung Zurich   (Switzerland)

^b CARINTHIA UNIVERSITY OF APPLIED SCIENCES   (Austria)

^c SWISS INSTITUTE FOR THE PREVENTION OF ALCOHOL AND DRUG PROBLEMS   (Switzerland)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

adolescents; brief intervention; Cannabis; prevention; problematic consumption

Indexed keywords

EID: 34548082460     PISSN: 14399903     EISSN: 1439989X     Source Type: Journal    
DOI: 10.1055/s-2005-858618     Document Type: Article

References (40)

1. Watson S, Benson J, Joy J. Marijuana and medicine: assesseing the science base: a summary of the 1999 Institute of Medicine report. Archives of General Psychiatry 2000; 57: 547–552
2. Gmel G, Rehm J, Kuntsche E et al. European School Survey Project on Alcohol and Other Drugs (ESPAD) in Switzerland: Wichtigste Ergebnisse 2003 und aktuelle Empfehlungen. Lausanne & Zürich: Schweizerische Fachstelle für Alkohol- und andere Drogenprobleme (SFA), 2004
3. Hibell B, Andersson B, Bjarnason T et al. The ESPAD Report 2003 - Alcohol and Other Drug Use Among Students in 35 European Countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs, CAN Council of Europe, Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou Group), 2004
4. Kuntsche E, Delgrande J, Schmid H. Wird Cannabis von 15-Jährigen in der Schweiz wie Tabak und Alkohol konsumiert? Ein faktorenanalytischer Ansatz. Wiener Zeitschrift für Suchtforschung 2002; 25 (4): 17–25
5. Täschner KL. Cannabisbezogene Störungen: Ein zentrales Thema der nächsten Jahre? Sucht 2004; 50 (5): 288–289
6. Kalant H. Medical use of cannabis: history and current status (review). Pain Res Manag 2001; 6 (2): 80–91
7. Rommelspacher H. Pharmakologische Verwendung von Cannabinoiden als Medikamente. Sucht 2004; 50 (5): 290–296
8. Ameri A. The effects of cannabinoids on the brain. Progress in Neurobiology 1999;58:315–348
9. Solowij N. Long-term effects of cannabis on the central nervous system In: Kalant H, Corrigal W, Smart R (Hrsg). The Health Effects of Cannabis. Toronto: ARF Books, 1999: 195–265
10. Wallmichrath I, Szabo B. Cannabinoide und neurale Signalübertragung. Sucht 2004; 50 (5): 297–308
11. Schneider M, Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory and the performance in a progressive ratio task in adult rats. Neuro psychopharamacology 2003; 28: 1760–1769
12. Pope H, Gruber A, Hudson J et al. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug and Alcohol Dependence 2003: 69: 303–310
13. Arseneault L, Cannon M, Witton J et al. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004; 184: 110–117
14. Schaub M, Rossler WRS. Cannabis and psychosis - a review. Schweiz Rundsch Med Prax 2004; 93 (23): 997–1002
15. Adamson S, Sellman J. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug and Alcohol Review 2003;22:309–315
16. Saunders JB, Aasland O, Babor R et al. Development of the Alcohol User Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption. Addiction 1993;88:791–804
17. White I, Altmanan D, Nanchahal K. Mortality in England and Wales attributable to any drinking, drinking above sensible limits and drinking above lowest-risk level. Addiction 2004; 99 (6): 749–756
18. SPSS. 12.0 Command Syntax Reference. Chicago: SPSS Inc. 2004
19. Rehm J, Gutjahr E, Gmel G. Alcohol and all-cause mortality: A pooled analysis. Contemporary Drug Problems 2001; 28 (3): 337–363
20. Schmid H, Graf M, Delgrandc Jordan M et al. Trends im Konsum psychoaktiver Substanzen von Schülerinnen und Schülern in der Schwciz. Lausanne: Schweizerische Fachstelle für Alkohol- und andere Drogen problemc, 2003
21. Narring F, Tschumper A, Inderwildi Bonivento L et al. Santé et styles de vie des adolescents âges de 16 à 20 ans en Suisse (2002). SMASH 2002: Swiss multicenter adolescent study on health 2002. Lausanne, Bern, Bellinzona: Institut universitaire de médicine sociale et préventive/Institut für Psychologie/Sezione sanitaria, 2003
22. Coffey C, Carlin J, Lynskey M et al. Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study. Br J Psychiatry 2003; 182 (4): 330–336
23. Coffey C, Carlin JB, Degenhardt L et al. Cannabis dependence in young adults: an Australian population study. Addiction 2002; 97 (2): 187–194
24. Perkonigg A, Lieb R, Höfler M et al. Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents. Addiction 1999; 94(11): 1663–1678
25. Taylor R, Fergusson D, Milne B et al.A longitudinal study of the effects of tobacco and cannabis exposure in young adults. Addiction 2002; 97: 1055–1061
26. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2004; 28: 849–863
27. Begg D, Langley J. Identifying predictors of persistent non-alcohol or drug-related risky driving behaviours among a cohort of young adults. Accident Analysis and Prevention 2004; 36: 1067–1071
28. Glendon A, Dorn L, Davis D et al. Age and gender differences in perceived accident likelihood and driver competences. Risk Anal 1996; 16 (6): 755–762
29. Kontos A. Perceived risk, risk taking, estimation of ability and injury among adolescent sport partcipants. Journal of Pediatric Psychology 2004; 29 (6): 447–455
30. Müller S, Geml G. Veränderungen des Einstiegsalters in den Cannabiskonsum: Ergebnisse der zweiten Schweizer Gesundheitsbefragung 1997. Soz Präventivmed 2002; 47: 1–10
31. Patton G, McMorris B, Toumbourou J et al. Puberty and the onset of substance use and abuse. Pediatrics 2004; 114(3): 300–306
32. Bolla K, Brown K, Eldreth D et al. Dose-related neurocognitive effects of marijuana use. Neurology 2002; 59: 1337–1343
33. Schneider M. Langfristige Folgen des chronischen Cannabiskonsums. Sucht 2004; 50(5): 309–319
34. Bundesamt für Statistik. Schweizerische Gesundheitsbefragung 2002. Erste Ergebnisse unter www.bfs.admin.ch
35. McCambridge J, Strang J. Age of first use and ongoing patterns of legal and illegal drug use in a sample of young Londoners. Subst Use Misuse 2005; 40(3): 313–319
36. Rist F, Demmel R, Hapke U et al. Riskanter schädlicher und abhängiger Alkoholkonsum: Screening, Diagnostik, Kurzintervention. Sucht 2004; 2: 102–112
37. Steinberg K, Roffman R, Carrol K et al. Tailoring cannabis dependence treatment for a diverse population. Addiction 2002; 97: 135–142
38. Moyer A, Finney J, Swearingen C et al. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction 2002; 97: 279–292
39. McCambridge J, Strang J. The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drugrelated risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 2004; 99 (1): 39–52
40. McCambridge J, Strang J. Deterioration over time in effect of Motivational Interviewing in reducing drug consumption and related risk among young people. Addiction 2005; 100 (4): 470–478